Vir Bio (VIR) reveals 24-week post-end-of-treatment data from a mid-stage trial for its Hep B therapy developed with Xencor ...

Experts highlight ten common requests received in their Gastroenterology advice and guidance service and explain how these ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from ...

Net Loss: For the first quarter of 2025, the Company generated a net loss attributable to its shareholders of $19.6 million, ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical outcomes of ...

Lab scientists at the Centers for Disease Control and Prevention had been analyzing blood samples for weeks to determine how dozens of patients across six states had become infected with viral ...

Natural seroconversion from HBeAg to anti-HBe is associated with sustained remission of hepatitis in about two thirds of patients. Reactivation to HBeAg can occur at any time. Recent follow-up ...

“A tenet of virology is that you go after one of the proteins on the surface that generates a good immune response, and that’s what you target. This principle has withstood the test of time because we ...